COMMUNIQUÉS West-GlobeNewswire

Catalyst Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update
07/08/2019
Firdapse ® Launch Momentum Continues with Second Quarter Net Revenues of $28.8 Million 409 Adult LEMS Patients Active on Firdapse as of June 30, 2019 Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow [...]
Y-mAbs to Announce Second Quarter 2019 Financial and Operating Results on August 14
07/08/2019
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its second quarter 2019 financial and operating results on Wednesday, [...]
The Cooper Companies to Participate in the Wells Fargo Securities Healthcare Conference
07/08/2019
PLEASANTON, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the 2019 Wells Fargo Securities Healthcare Conference in Boston, MA, on September 5, 2019. Albert G. White [...]
Dynavax Technologies Announces Proposed Public Offering of Common Stock, Non-Voting Preferred Stock and Warrants to Purchase Common Stock
07/08/2019
EMERYVILLE, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and commercializing novel vaccines, [...]
CytomX Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
07/08/2019
-Company to Host a Conference Call Today, August 7, 2019, at 5:00 p.m. ET / 2:00 p.m. PT- SOUTH SAN FRANCISCO, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage [...]
ChromaDex Receives Positive Opinion on Nicotinamide Riboside as a Novel Food from the World-Leading European Food Safety Authority (EFSA)
07/08/2019
ChromaDex Achieves Milestone for Nicotinamide Riboside in EU Regulatory Process, Advances to European Commission for Review LOS ANGELES, Aug. 07, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today announced [...]
CymaBay Reports Second Quarter 2019 Financial Results and Provides Corporate Update
07/08/2019
Conference call and webcast today at 4:30p.m. ET NEWARK, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies [...]
Rubius Therapeutics to Announce Second Quarter 2019 Financial Results
07/08/2019
CAMBRIDGE, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new [...]
Nephros Reports Second Quarter Financial Results
07/08/2019
Product Revenue up 88% over Q2 2018; Reiterates 2019 Full-Year Revenue Guidance SOUTH ORANGE, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high [...]
DBV Technologies Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Peanut for the Treatment of Peanut Allergy
07/08/2019
Montrouge, France, August 7, 2019 DBV Technologies Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Peanut for the Treatment of Peanut Allergy DBV Technologies (Euronext: DBV - ISIN [...]
DBV Technologies soumet la demande de licence biologique à la FDA pour Viaskin Peanut dans le traitement de l’allergie à l’arachide
07/08/2019
Montrouge, France, le 7 août (22 h 00 CEST) 2019 DBV Technologies soumet la demande de licence biologique à la FDA pour Viaskin Peanut dans le traitement de l’allergie à l’arachide DBV Technologies (Euronext : DBV - [...]
Zosano Pharma to Host Conference Call on Second Quarter 2019 Financial Results and Provide Operational Update
07/08/2019
FREMONT, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and webcast on Wednesday, [...]
Aravive Reports Second Quarter 2019 Financial Results and Provides Recent Corporate Updates
07/08/2019
HOUSTON, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of life-threatening diseases, including cancer [...]
miRagen Reports Second Quarter 2019 Results; Regains Global Rights to MRG-110 and Announces Corporate Restructuring
07/08/2019
miRagen to regain global rights to MRG-110 after Servier provides notice of portfolio realignment; expects to announce Phase 1 data during the second half of 2019 Company anticipates reporting primary endpoint data from [...]
Kezar Life Sciences Reports Second Quarter 2019 Financial Results and Provides Business Update
07/08/2019
Promising data reported from the Phase 1b portion of MISSION, a first-in-patient study of KZR-616; Phase 2 portion of MISSION in LN patients has been initiated Phase 2 PRESIDIO and MARINA trials have been initiated [...]
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2019 Financial Results
07/08/2019
REDWOOD CITY, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2019 Financial Results
07/08/2019
Data presented at ASCO and EHA suggest potential disease-modifying activity of CPI-0610 across the spectrum of myelofibrosis (MF) parameters, with multiple potential pathways for approval The EZH2 franchise continues to [...]
GBT Reports Recent Business Progress and Second Quarter 2019 Financial Results
07/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today reported recent business progress and financial results for the second quarter ended June 30, 2019 [...]
OpGen Reports Second Quarter 2019 Financial Results and Provides Business Update
07/08/2019
Revenue up 28% Quarter-over-Quarter Progression of 510(k) submission to the FDA for clearance of the Acuitas® AMR Gene Panel test for bacterial isolates Conference call to be held at 4:30 p.m. Eastern Time today [...]

Pages